UID653610
阅读权限20
专业分
贡献分
爱医币
鲜花
注册时间2008-4-4
|
胃食管反流病8大诱因
常规使用。
(2)采用胆管空肠Roux-en-Y吻介解除胆道梗阻.可附
加胃空肠吻介.以解除或预防}一二指肠梗阻。过去经常忽
视胰管梗阻造成的腹痛和胰腺内外分泌功能障碍,在行胆
肠、胃肠吻介的同时.附加胰管空肠吻介.可解决胰管高压
造成的疼痛.胰腺外分泌功能小足的状况亦有所改善。
(3)随着内镜和介入技术的发展,通过内镜放置胆道
内支架.胰管内支架和肠道内支架.以及腹腔镜胆肠吻介、
胃肠吻介等乎段解决胰头癌病人的黄疽、l一二指肠梗阻等
症状.已经得到越来越多的应用。
3. 5综介治疗
3. 5. 1化疗和放疗胰腺癌术前及术后化疗或吓口)放疗
仍然存在争议.与5一FCT相比.吉西他滨(G}ncitabine)在
提高生存质量方而略显优势。分子靶向药物的疗效正在评
估中。
放疗包括术前放疗、术中放疗、适形调强放疗、放射性
核索内照射治疗和放化疗。
3. 5. 2其它辅助治疗包括射频组织灭活、冷冻、高能聚
焦超声、Y刃及生物治疗等.目前尚没有明确证据显示其能
够延长生存期。
胰腺癌诊断和治疗流程见图to
2003, 6 ( 5):349一35&
Aganval B, Abu-Hamda E,Molke KL et al Endoscopic ultra-
Fund-guided fine needle a}imtion and multidetechm }iml CT
in the diagnosis of pancreatic cancer[J].Am J Gashoenterol,
2004,99(5):844一850.
Haln U, Schumann T, Schie&e 1, et al Decrease of CA 19-9
during chemotherapy with gemcitabine predicts survival tine in
patients with advanced pancreatic cancer[J].B r J Cancer,
2000,82(5):1013一IOIG
LiD, Xie K,Wo1ffR, et al Pancreatic cancer[J].Lancet, 2004,
363(9414):1049一1057.
Pisters Pv\,Hudec WA, Hess KR,et al Effect of preoperative
biliary decanpression on pancreaticoduodenect<xny-as}ciated
morbidity in 300 consecutive patients[J].Ann Surg, 2001, 234
(1):47一55.
Tseng JF, Raut CP, Lee JE, et al Pancreaticoduodenechnny with
vascular resection: margin status and survival duration[J].J
Gastrointest Surg, 2004, 8 ( 8):93s一949; discussion 949一950.
Pisters P, Brennan M. Regonal lymph node dissection for pan-
creaticadenocarcinoma In: EvansD, PistersP, AbbmzzeseJ,
eds Pancreatic Cancer[M].New York:印ringer V erlag, 2002:
139一151.
高危人群.....~令绿色通道阅卜~~~~~-继续随访
丘全二三匕一=示
肿瘤标志物检测
影像学检查
组织病理活检
—一一一门尸一一一一一,厂
{
确定诊断
排除诊断
番
可切除月..~可切除性评估
备
根治性手术
一冬一
综合治疗....卜
...叫卜不可切除
冬一
姑息治疗
一备
月...~放、化疗
图1胰腺癌诊治流程
参考文献
f21
[31
Jemal A, Siegel R, Ward E, et al Cancer statistics[J].CA
Cancer) C1in,2006,56(2):IOG一130.
Patel AV, Rodriguez C, Bemstein L, et al Obesity, recreational
physical activity, and risk of pancreatic cancer in a large U. S
Cohort[ J].Cancer Epideme}l Bianarkers Prev, 2005, 14 (2):
459一4GG
Pongpra}bchai S, Chari ST Managementof Patients atH igh R isk
for Pancreatic Cancer[J].Curr Treat Options Gastroenterol,
[4]
[5]
[G]
f}]
[s]
[9]
[10]
[11]
[12]
[13]
[14]
[IS]
[IG }
Henne书mns D, Vogel 1, Luttges J, et al Surgery for ductal
adenocarcinomaofthepancreatichead: staging, canplications,
and survival after regional versus extended lymphadenectcxny
[J].Wor1dJ Surg, 2000,24(5):595一G01.
Gouma DJ, van Geenen RC, van Gulik },et al Rates of
canplications and death after pancreasticoduo一den echnn y:
risk fachms and the inpact of ho}ihl volume[J].Ann Surg,
2000,232 (G):78G一795.
Neoph}lemos JP, Sh}cken DD, Friess H, et al European Study
Group for Pancreatic Cancer A random ized trial of chemoradio-
therapy and chemotherapy after resecte}n of pancreatic cancer
[J].N Eng1 J Med, 2004, 350 (12):1200一1210.
KoshyMC, Landry JC, Cavanaugh SX, et al A challenge h} the
therapeutic nihilisn of ESPAC一1[J].IntJ RadiatOncolBiol
Phys,2005,61(4):9G5一96G
Neuhuas P, Oettle H, Post S A random ized, projective, multi-
center, phase川trial of adjuvant chemotherapy with gemcit-
abine vs observation in patientswith resected pancreatic cancer
[J].J Clin Oncol (meeting Abstracts),2005, 23: LBA4013.
Moore Al\,Cardenes H, Johnron CS, et al A phase II study of
gemcitabine in canbination with mdiate}n therapy in patients
with bcalized, unresectable, pancreatic cancer a HoosierOncol-
ogy Group Trial (abstract). ASCO AnnualMeeting Proceedings
(post-meeting edition) [J].J Clin Oncol, 2004, 22: 4105.
Polbck RE, Dorosh}v JH, Khayat D, et al UICC Manual of
clinical oncobgy[M].2004 by John W iley&Sons, Inc
(2007一08一08I}X稿) |
|